Comparing Teriparatide and Bisphosphonates for Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis of...

Area of Science:

• Bone Metabolism and Osteoporosis Research
• Pharmacological Interventions for Bone Health

Background:

• Osteoporosis is a prevalent bone disorder, particularly in post-menopausal women, increasing fracture risk.
• Bone Mineral Density (BMD) measured by DEXA scan is a key diagnostic and classification tool.
• Effective management of osteoporosis requires a multidisciplinary approach due to its global impact.

Purpose of the Study:

• To evaluate the efficacy and safety of teriparatide in managing osteoporosis.
• To identify optimal osteoporosis treatments with favorable outcomes and minimal adverse events.

Main Methods:

• A comprehensive literature search was performed across PubMed, Embase, Cochrane, and Google Scholar.
• Fifteen Randomized Controlled Trials (RCTs) meeting inclusion criteria were analyzed.
• The study adhered to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines.

Main Results:

• Teriparatide use was associated with a significant reduction in vertebral and non-vertebral fractures.
• Increased Bone Mineral Density (BMD) was observed in patients treated with teriparatide.
• A notable reduction in the overall mortality rate was observed in the teriparatide intervention group.

Conclusions:

• Teriparatide demonstrated clinically significant benefits in managing osteoporosis, including fracture reduction and improved BMD.
• Further research is needed to address confounding factors and solidify definitive outcomes.
• Continued investigation into teriparatide and other osteoporosis treatments is essential for advancing patient care.